This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Grandis, Inc.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Gwenaël Dehon: Innovator in PET Radiotracers
Introduction
Gwenaël Dehon is a notable inventor based in Seneffe, Belgium. He has made significant contributions to the field of medical imaging, particularly in the development of positron emission tomography (PET) radiotracers. With a total of 2 patents, his work is paving the way for advancements in imaging techniques.
Latest Patents
Dehon's latest patents include a groundbreaking [F]-labelled lactate derivative as a PET radiotracer. This innovative tracer, [F]-3-fluoro-2-hydroxypropionic acid, is designed for imaging lactate uptake in living cells, especially in humans. The patent also covers a process for the radiosynthesis of this compound, as well as its use in medical imaging applications.
Career Highlights
Gwenaël Dehon is currently associated with Grandis, Inc., where he continues to push the boundaries of medical imaging technology. His expertise in radiotracer development has positioned him as a key figure in the field.
Collaborations
Throughout his career, Dehon has collaborated with esteemed colleagues such as Pierre Sonveaux and Daniel Labar. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Gwenaël Dehon's contributions to the field of PET radiotracers exemplify the impact of innovative thinking in medical imaging. His work not only advances scientific knowledge but also holds the potential to improve patient care through enhanced imaging techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile